| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 77,241 | 6,408 |
| Net effect of exchange rate fluctuations | -2,034 | -9,256 |
| Net decrease in cash and cash equivalents | -11,457 | -11,948 |
| Cash and cash equivalents at beginning of period | 58,404 | - |
| Cash and cash equivalents at end of period | 46,947 | - |
BIOREGENX, INC. (BRGX)
BIOREGENX, INC. (BRGX)